Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDK7 Antikörper (AA 212-341)

CDK7 Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7148902
  • Target Alle CDK7 Antikörper anzeigen
    CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
    Bindungsspezifität
    • 31
    • 13
    • 7
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 212-341
    Reaktivität
    • 98
    • 28
    • 11
    • 7
    • 6
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 79
    • 20
    • 1
    Kaninchen
    Klonalität
    • 73
    • 27
    Polyklonal
    Konjugat
    • 54
    • 6
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CDK7 Antikörper ist unkonjugiert
    Applikation
    • 76
    • 34
    • 32
    • 17
    • 15
    • 14
    • 14
    • 9
    • 9
    • 8
    • 8
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Cyclin-dependent kinase 7 protein (212-341AA)
    Isotyp
    IgG
    Top Product
    Discover our top product CDK7 Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
    Andere Bezeichnung
    CDK7 (CDK7 Produkte)
    Synonyme
    CAK1 antikoerper, CDKN7 antikoerper, HCAK antikoerper, MO15 antikoerper, STK1 antikoerper, p39MO15 antikoerper, AI323415 antikoerper, AI528512 antikoerper, C230069N13 antikoerper, Cdkn7 antikoerper, Crk4 antikoerper, CD 7 antikoerper, CDK7 antikoerper, CG3319 antikoerper, DmCDK7 antikoerper, DmCdk7 antikoerper, DmMO15 antikoerper, DmMo15 antikoerper, Dmcdk7 antikoerper, Dmel\\CG3319 antikoerper, Mo15 antikoerper, cdk-7 antikoerper, cdk7 antikoerper, dCdk7 antikoerper, p40[MO15] antikoerper, p40MO15 antikoerper, stk1 antikoerper, zgc:85821 antikoerper, cak1 antikoerper, cdkn7 antikoerper, p39mo15 antikoerper, cyclin dependent kinase 7 antikoerper, cyclin-dependent kinase 7 antikoerper, Cyclin-dependent kinase 7 antikoerper, cyclin-dependent kinase 7 L homeolog antikoerper, CDK7 antikoerper, Cdk7 antikoerper, cdk7.L antikoerper, cdk7 antikoerper
    Hintergrund

    Background: Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53, this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

    Aliases: 39 kDa protein kinase antibody, CAK antibody, CAK1 antibody, Cdk activating kinase antibody, CDK-activating kinase 1 antibody, CDK-activating kinase antibody, cdk7 antibody, CDK7_HUMAN antibody, CDKN7 antibody, Cell division protein kinase 7 antibody, Cyclin dependent kinase 7 antibody, cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase) antibody, Cyclin-dependent kinase 7 antibody, HCAK antibody, Homolog of Xenopus MO15 Cdk activating kinase antibody, Kinase subunit of CAK antibody, MO15 antibody, MO15, Xenopus, homolog of antibody, P39 Mo15 antibody, p39MO15 antibody, Serine threonine kinase Stk1 antibody, Serine/threonine protein kinase 1 antibody, Serine/threonine protein kinase MO15 antibody, STK1 antibody, TFIIH basal transcription factor complex kinase subunit antibody

    UniProt
    P50613
    Pathways
    Zellzyklus, DNA Reparatur, Intracellular Steroid Hormone Receptor Signaling Pathway, Mitotic G1-G1/S Phases, M Phase
Sie sind hier:
Kundenservice